Antibiotic azithromycin not found to affect airway microbiome in CF
While adding azithromycin to another antibiotic, called tobramycin, showed benefits in children with cystic fibrosis (CF) and early Pseudomonas aeruginosa infections, these outcomes were not due to the medication’s effects on the community of microbes — known as the microbiome — living in the airways. That’s according to a new…